Porcine Vaccine Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Porcine Vaccine Market’s Growth Rate Evolve Over the Forecast Period to 2034?
The market for porcine vaccines has notably expanded in the past few years. It is projected to increase from $1.89 billion in 2024 to $2.06 billion in 2025, experiencing a compound annual growth rate (CAGR) of 8.8%. The surge during the previous period is due to factors such as outbreaks of diseases and their control measures, a worldwide rise in pork intake, the upscaling of pig farming, governmental disease control schemes, and programs promoting awareness and education.
Expectations for the porcine vaccine market suggest a significant expansion in the coming years, with an anticipated growth to $2.96 billion in 2029 with a compound annual growth rate (CAGR) of 9.5%. The expected growth in this period is due to factors such as growth in pig farming globally, increasing disease issues, strict regulatory requirements and adherence, advancements in vaccine technology, international trade and disease risk reduction strategies. Key trends for this upcoming period are region-specific vaccine customization, integration of biotech in vaccine creation, growing worry over zoonotic diseases, the use of genomics in vaccine production, and an increase in research and development investments.
What Drivers Are Shaping the Growth of the porcine vaccine Market?
The escalating occurrence of swine disease is anticipated to foster the expansion of the porcine vaccine market. Swine flu, a respiratory ailment impacting pigs, is ordinarily triggered by the type A influenza virus that often provokes influenza epidemics in these animals. Porcine vaccines are administered to pigs, with their immune systems responding to the vaccine by remembering the pathogen and inducing an immunogenic response. These inoculations equip the pig’s immune system to combat pathogens and fend off the illness by triggering an anamnestic response upon meeting the same pathogen. For example, in September 2024, it was suggested by the UK Government that an African swine fever (ASF) outbreak might critically harm the UK’s pig industry worth £8 billion, and its annual £600 million exports of pork and related products. The projected economic impact of such an outbreak could range from £10 million to £100 million. Hence, the escalating occurrence of swine disease is fueling the growth of the porcine vaccine market.
Request Your Free Porcine Vaccine Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp
Who Are the Influential Players Reshaping the Porcine Vaccine Market Landscape?
Major companies operating in the porcine vaccine market include:
• Sanofi Pasteur Inc._x000D_
• Boehringer Ingelheim International GmbH_x000D_
• Zoetis Inc._x000D_
• Arko Laboratories Limited_x000D_
• Merck Animal Health_x000D_
What New and Evolving Trends Are Having a Lasting Impact on the Porcine Vaccine Market?
Prominent enterprises in the porcine vaccine market are leveraging strategic collaborations to augment their R&D capacities and solidify their competitive standing in the fast-evolving animal health sector. This partnership capitalizes on TVG’s proficiency in vaccine technology and Pirbright’s specialization in African swine fever (ASF) research to accelerate the vaccine development process and evolve innovative methods to drastically enhance swine health. For example, in May 2024, The Pirbright Institute, based in the UK, joined forces with The Vaccine Group (TVG), also based in the UK, with the aim of manufacturing a vaccine for African swine fever (ASF). The research is focused on generating vaccines to protect against ASF using bovine herpesvirus 4 (BoHV-4) as a base. This approach utilises cutting-edge developments in ASF vaccine research and pig immunology to design more effective vaccines. The undertaking is financially backed by the U.K.’s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC).
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report
What Are the Core Segments of the Porcine Vaccine Market, and How Do They Contribute to Growth?
The porcine vaccine market covered in this report is segmented –
1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines
2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications
3) By End User: Veterinary Hospitals, Hog or Pig Production Farm
Subsegments:
1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines
2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines
3) By Toxoid Vaccines: Inactivated Toxins
4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines
5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines
6) By DNA Vaccines: Plasmid DNA Vaccines
Which Geographic Locations Are Critical to the Growth of the Porcine Vaccine Market?
North America is the largest region in the porcine vaccine market in 2024. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Defining Aspects of the Porcine Vaccine Market Landscape?
Porcine vaccines are a medical and pharmaceutical treatment that improves the health of pigs by shielding them from different bacteria, viruses, and other infections. It is used to increase the efficacy of protecting pigs from harmful ailments while increasing the output of top-notch meat for human consumption.
Browse Through More Similar Reports By The Business Research Company:
Animal Antibiotics and Antimicrobials Global Market Report 2024
Probiotics In Animal Feed Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/probiotics-in-animal-feed-global-market-report
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
